nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—CYP2D6—Niacin—coronary artery disease	0.148	0.173	CbGbCtD
Tripelennamine—CYP2D6—Timolol—coronary artery disease	0.138	0.161	CbGbCtD
Tripelennamine—CYP2D6—Captopril—coronary artery disease	0.121	0.141	CbGbCtD
Tripelennamine—CYP2D6—Simvastatin—coronary artery disease	0.117	0.137	CbGbCtD
Tripelennamine—CYP2D6—Pravastatin—coronary artery disease	0.115	0.134	CbGbCtD
Tripelennamine—CYP2D6—Lovastatin—coronary artery disease	0.115	0.134	CbGbCtD
Tripelennamine—CYP2D6—Atorvastatin—coronary artery disease	0.104	0.122	CbGbCtD
Tripelennamine—Tamoxifen—SULT1A1—coronary artery disease	0.00186	0.11	CrCbGaD
Tripelennamine—Bepridil—ATP1A1—coronary artery disease	0.00158	0.0935	CrCbGaD
Tripelennamine—Doxepin—HRH2—coronary artery disease	0.00122	0.0723	CrCbGaD
Tripelennamine—Rosiglitazone—PPARG—coronary artery disease	0.00108	0.064	CrCbGaD
Tripelennamine—Dextropropoxyphene—OPRD1—coronary artery disease	0.000946	0.056	CrCbGaD
Tripelennamine—Amitriptyline—HRH2—coronary artery disease	0.000946	0.0559	CrCbGaD
Tripelennamine—Phenoxybenzamine—SLC22A3—coronary artery disease	0.000805	0.0476	CrCbGaD
Tripelennamine—Rosiglitazone—CYP2C19—coronary artery disease	0.000733	0.0434	CrCbGaD
Tripelennamine—Methadone—OPRD1—coronary artery disease	0.000642	0.038	CrCbGaD
Tripelennamine—Tamoxifen—ESR2—coronary artery disease	0.000523	0.031	CrCbGaD
Tripelennamine—Imipramine—SLC22A3—coronary artery disease	0.00051	0.0301	CrCbGaD
Tripelennamine—Amitriptyline—OPRD1—coronary artery disease	0.000499	0.0295	CrCbGaD
Tripelennamine—Carbinoxamine—CYP2C19—coronary artery disease	0.000461	0.0272	CrCbGaD
Tripelennamine—Cyclobenzaprine—HTR2A—coronary artery disease	0.000454	0.0269	CrCbGaD
Tripelennamine—Rosiglitazone—ALB—coronary artery disease	0.000407	0.0241	CrCbGaD
Tripelennamine—Brompheniramine—CYP2C19—coronary artery disease	0.000399	0.0236	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRB2—coronary artery disease	0.000368	0.0218	CrCbGaD
Tripelennamine—Imipramine—HTR7—coronary artery disease	0.000324	0.0191	CrCbGaD
Tripelennamine—Tamoxifen—ESR1—coronary artery disease	0.000322	0.0191	CrCbGaD
Tripelennamine—Amitriptyline—HTR7—coronary artery disease	0.000322	0.019	CrCbGaD
Tripelennamine—Diphenhydramine—CYP2C19—coronary artery disease	0.000266	0.0157	CrCbGaD
Tripelennamine—Tamoxifen—CYP2C19—coronary artery disease	0.000259	0.0153	CrCbGaD
Tripelennamine—Doxepin—CYP2C19—coronary artery disease	0.000258	0.0153	CrCbGaD
Tripelennamine—Methadone—CYP2C19—coronary artery disease	0.000257	0.0152	CrCbGaD
Tripelennamine—Promazine—CYP2C19—coronary artery disease	0.000229	0.0136	CrCbGaD
Tripelennamine—Doxepin—HTR2A—coronary artery disease	0.000209	0.0124	CrCbGaD
Tripelennamine—Imipramine—CYP2C19—coronary artery disease	0.000201	0.0119	CrCbGaD
Tripelennamine—Amitriptyline—CYP2C19—coronary artery disease	0.000199	0.0118	CrCbGaD
Tripelennamine—Promazine—HTR2A—coronary artery disease	0.000186	0.011	CrCbGaD
Tripelennamine—Imipramine—HTR2A—coronary artery disease	0.000163	0.00963	CrCbGaD
Tripelennamine—Amitriptyline—HTR2A—coronary artery disease	0.000162	0.00957	CrCbGaD
Tripelennamine—Amitriptyline—ALB—coronary artery disease	0.000111	0.00655	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—EDNRA—coronary artery disease	7.79e-05	0.00062	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	7.76e-05	0.000618	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADRB1—coronary artery disease	7.75e-05	0.000617	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR7—coronary artery disease	7.72e-05	0.000615	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ITGA2B—coronary artery disease	7.68e-05	0.000612	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DVL1—coronary artery disease	7.68e-05	0.000612	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	7.66e-05	0.00061	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—POMC—coronary artery disease	7.64e-05	0.000609	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PGM1—coronary artery disease	7.58e-05	0.000603	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CCL2—coronary artery disease	7.48e-05	0.000596	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OPRD1—coronary artery disease	7.45e-05	0.000593	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL4—coronary artery disease	7.45e-05	0.000593	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GHR—coronary artery disease	7.45e-05	0.000593	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—PIK3CA—coronary artery disease	7.44e-05	0.000592	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—KNG1—coronary artery disease	7.33e-05	0.000584	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—BDKRB2—coronary artery disease	7.32e-05	0.000583	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL12—coronary artery disease	7.32e-05	0.000583	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PYGB—coronary artery disease	7.32e-05	0.000583	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CKB—coronary artery disease	7.32e-05	0.000583	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGTR1—coronary artery disease	7.29e-05	0.000581	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PLCB1—coronary artery disease	7.16e-05	0.00057	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TLE4—coronary artery disease	7.14e-05	0.000569	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MEF2A—coronary artery disease	7.14e-05	0.000569	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL10—coronary artery disease	7.13e-05	0.000568	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR7—coronary artery disease	7.01e-05	0.000558	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOA2—coronary artery disease	6.96e-05	0.000554	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADRB2—coronary artery disease	6.92e-05	0.000551	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—DLAT—coronary artery disease	6.88e-05	0.000548	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM2—coronary artery disease	6.88e-05	0.000548	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COX5B—coronary artery disease	6.88e-05	0.000548	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLIN1—coronary artery disease	6.88e-05	0.000548	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PFKFB3—coronary artery disease	6.88e-05	0.000548	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AVPR1A—coronary artery disease	6.87e-05	0.000547	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCE—coronary artery disease	6.83e-05	0.000544	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—KNG1—coronary artery disease	6.66e-05	0.000531	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	6.65e-05	0.00053	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—UTS2—coronary artery disease	6.64e-05	0.000529	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGTR1—coronary artery disease	6.62e-05	0.000527	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SULT1E1—coronary artery disease	6.52e-05	0.000519	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NR4A1—coronary artery disease	6.49e-05	0.000517	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL10—coronary artery disease	6.47e-05	0.000515	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HDAC9—coronary artery disease	6.43e-05	0.000512	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLCB3—coronary artery disease	6.43e-05	0.000512	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—P2RY12—coronary artery disease	6.43e-05	0.000512	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CX3CR1—coronary artery disease	6.36e-05	0.000507	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASR—coronary artery disease	6.36e-05	0.000507	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADRB2—coronary artery disease	6.28e-05	0.0005	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CX3CL1—coronary artery disease	6.24e-05	0.000497	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—P4HB—coronary artery disease	6.24e-05	0.000497	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GNA12—coronary artery disease	6.24e-05	0.000497	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BDKRB1—coronary artery disease	6.24e-05	0.000497	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKR1B1—coronary artery disease	6.22e-05	0.000496	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HK2—coronary artery disease	6.22e-05	0.000496	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCE—coronary artery disease	6.2e-05	0.000494	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—EDN1—coronary artery disease	6.18e-05	0.000492	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCL5—coronary artery disease	6.13e-05	0.000489	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PPP3R1—coronary artery disease	6.12e-05	0.000488	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADM—coronary artery disease	6.07e-05	0.000483	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CSF2—coronary artery disease	6.04e-05	0.000481	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC27A1—coronary artery disease	5.97e-05	0.000475	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDE4B—coronary artery disease	5.92e-05	0.000471	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CYBB—coronary artery disease	5.92e-05	0.000471	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CXCL8—coronary artery disease	5.91e-05	0.000471	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MMP3—coronary artery disease	5.9e-05	0.00047	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	5.89e-05	0.000469	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CPT1B—coronary artery disease	5.85e-05	0.000466	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LCAT—coronary artery disease	5.85e-05	0.000466	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA4—coronary artery disease	5.74e-05	0.000457	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EDN1—coronary artery disease	5.61e-05	0.000447	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL5—coronary artery disease	5.57e-05	0.000444	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PDHA1—coronary artery disease	5.55e-05	0.000442	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCLM—coronary artery disease	5.55e-05	0.000442	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCD—coronary artery disease	5.53e-05	0.00044	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CSF2—coronary artery disease	5.49e-05	0.000437	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR3—coronary artery disease	5.41e-05	0.000431	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2A—coronary artery disease	5.41e-05	0.000431	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—C3—coronary artery disease	5.4e-05	0.00043	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP11B2—coronary artery disease	5.37e-05	0.000428	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TXNRD1—coronary artery disease	5.37e-05	0.000428	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CRK—coronary artery disease	5.34e-05	0.000425	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC22A3—coronary artery disease	5.29e-05	0.000421	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VWF—coronary artery disease	5.27e-05	0.00042	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SH2B3—coronary artery disease	5.27e-05	0.00042	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ATP2A2—coronary artery disease	5.27e-05	0.00042	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOC3—coronary artery disease	5.24e-05	0.000417	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ARNTL—coronary artery disease	5.21e-05	0.000415	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HADH—coronary artery disease	5.21e-05	0.000415	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LDLR—coronary artery disease	5.21e-05	0.000415	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGT—coronary artery disease	5.13e-05	0.000409	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PPP2CA—coronary artery disease	5.11e-05	0.000407	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL2—coronary artery disease	5.09e-05	0.000405	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL3—coronary artery disease	5.09e-05	0.000405	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—F2R—coronary artery disease	5.03e-05	0.000401	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SDC1—coronary artery disease	5.03e-05	0.000401	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	5.02e-05	0.0004	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	4.94e-05	0.000394	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX2—coronary artery disease	4.94e-05	0.000394	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA2—coronary artery disease	4.94e-05	0.000394	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGB—coronary artery disease	4.92e-05	0.000392	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	4.91e-05	0.000391	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—C3—coronary artery disease	4.9e-05	0.000391	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX4—coronary artery disease	4.88e-05	0.000389	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCG5—coronary artery disease	4.88e-05	0.000389	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HK1—coronary artery disease	4.88e-05	0.000389	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SULT1A1—coronary artery disease	4.88e-05	0.000389	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRB—coronary artery disease	4.87e-05	0.000388	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HADHA—coronary artery disease	4.82e-05	0.000384	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—THBS1—coronary artery disease	4.8e-05	0.000382	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA1—coronary artery disease	4.77e-05	0.00038	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PSMA6—coronary artery disease	4.75e-05	0.000378	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PSMB5—coronary artery disease	4.75e-05	0.000378	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—F2—coronary artery disease	4.74e-05	0.000378	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LPA—coronary artery disease	4.72e-05	0.000376	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGT—coronary artery disease	4.66e-05	0.000371	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRA—coronary artery disease	4.6e-05	0.000366	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CYBA—coronary artery disease	4.58e-05	0.000365	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRB1—coronary artery disease	4.58e-05	0.000365	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLCB3—coronary artery disease	4.57e-05	0.000364	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DUSP6—coronary artery disease	4.56e-05	0.000363	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA5—coronary artery disease	4.52e-05	0.00036	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLAT—coronary artery disease	4.48e-05	0.000357	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—P4HB—coronary artery disease	4.43e-05	0.000353	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	4.35e-05	0.000347	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL12—coronary artery disease	4.33e-05	0.000344	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	4.33e-05	0.000344	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—POMC—coronary artery disease	4.32e-05	0.000344	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—F2—coronary artery disease	4.31e-05	0.000343	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	4.29e-05	0.000342	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JUNB—coronary artery disease	4.25e-05	0.000338	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLCB1—coronary artery disease	4.23e-05	0.000337	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR7—coronary artery disease	4.14e-05	0.00033	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—VCAN—coronary artery disease	4.1e-05	0.000327	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDOA—coronary artery disease	4.07e-05	0.000324	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—DCN—coronary artery disease	3.95e-05	0.000315	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ITGAV—coronary artery disease	3.95e-05	0.000314	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KNG1—coronary artery disease	3.93e-05	0.000313	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—POMC—coronary artery disease	3.92e-05	0.000312	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CREB1—coronary artery disease	3.92e-05	0.000312	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGTR1—coronary artery disease	3.91e-05	0.000312	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.84e-05	0.000306	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	3.84e-05	0.000306	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	3.83e-05	0.000305	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	3.82e-05	0.000304	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLG—coronary artery disease	3.81e-05	0.000304	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	3.75e-05	0.000298	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HBA1—coronary artery disease	3.75e-05	0.000298	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	3.75e-05	0.000298	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LIPC—coronary artery disease	3.75e-05	0.000298	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOC3—coronary artery disease	3.72e-05	0.000297	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	3.71e-05	0.000296	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LDLR—coronary artery disease	3.7e-05	0.000295	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	3.66e-05	0.000292	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	3.66e-05	0.000292	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.66e-05	0.000291	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.66e-05	0.000291	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	3.65e-05	0.000291	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—S100B—coronary artery disease	3.65e-05	0.00029	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCLC—coronary artery disease	3.61e-05	0.000288	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CETP—coronary artery disease	3.61e-05	0.000288	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	3.61e-05	0.000288	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SDC1—coronary artery disease	3.57e-05	0.000285	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KITLG—coronary artery disease	3.57e-05	0.000284	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	3.57e-05	0.000284	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	3.49e-05	0.000278	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP3—coronary artery disease	3.49e-05	0.000278	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.38e-05	0.000269	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.38e-05	0.000269	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOB—coronary artery disease	3.37e-05	0.000268	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	3.34e-05	0.000266	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	3.32e-05	0.000265	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDN1—coronary artery disease	3.32e-05	0.000264	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CTGF—coronary artery disease	3.3e-05	0.000263	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL5—coronary artery disease	3.29e-05	0.000262	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GOT2—coronary artery disease	3.27e-05	0.00026	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.27e-05	0.00026	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CSF2—coronary artery disease	3.24e-05	0.000258	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF1—coronary artery disease	3.24e-05	0.000258	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LPL—coronary artery disease	3.22e-05	0.000256	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	3.19e-05	0.000254	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	3.19e-05	0.000254	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	3.11e-05	0.000247	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	3.03e-05	0.000242	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	3.02e-05	0.00024	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.01e-05	0.000239	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	2.96e-05	0.000236	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.91e-05	0.000232	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	2.9e-05	0.000231	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—C3—coronary artery disease	2.9e-05	0.000231	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GOT1—coronary artery disease	2.82e-05	0.000225	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GGT1—coronary artery disease	2.82e-05	0.000225	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	2.76e-05	0.00022	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGT—coronary artery disease	2.75e-05	0.000219	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOE—coronary artery disease	2.7e-05	0.000215	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LEP—coronary artery disease	2.7e-05	0.000215	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOA1—coronary artery disease	2.67e-05	0.000212	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KDR—coronary artery disease	2.64e-05	0.00021	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	2.62e-05	0.000209	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ESR1—coronary artery disease	2.57e-05	0.000205	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FN1—coronary artery disease	2.54e-05	0.000203	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—F2—coronary artery disease	2.54e-05	0.000203	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.53e-05	0.000202	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	2.53e-05	0.000202	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	2.51e-05	0.0002	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.51e-05	0.0002	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.5e-05	0.000199	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAT—coronary artery disease	2.47e-05	0.000196	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KIT—coronary artery disease	2.43e-05	0.000194	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOB—coronary artery disease	2.39e-05	0.000191	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	2.34e-05	0.000186	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.33e-05	0.000185	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—POMC—coronary artery disease	2.32e-05	0.000185	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.32e-05	0.000185	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LPL—coronary artery disease	2.29e-05	0.000182	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.27e-05	0.000181	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.26e-05	0.00018	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX1—coronary artery disease	2.23e-05	0.000178	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.23e-05	0.000177	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.22e-05	0.000177	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CD36—coronary artery disease	2.17e-05	0.000173	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.14e-05	0.000171	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.12e-05	0.000169	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.12e-05	0.000169	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.06e-05	0.000164	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.05e-05	0.000163	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.02e-05	0.000161	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.96e-05	0.000156	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AGT—coronary artery disease	1.96e-05	0.000156	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.92e-05	0.000153	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOE—coronary artery disease	1.92e-05	0.000153	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.89e-05	0.000151	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.79e-05	0.000143	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.73e-05	0.000138	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.72e-05	0.000137	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.7e-05	0.000136	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.67e-05	0.000133	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARG—coronary artery disease	1.67e-05	0.000133	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—POMC—coronary artery disease	1.65e-05	0.000131	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.62e-05	0.000129	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.57e-05	0.000125	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALB—coronary artery disease	1.5e-05	0.00012	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.46e-05	0.000116	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.44e-05	0.000114	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.34e-05	0.000106	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.31e-05	0.000105	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.31e-05	0.000104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.14e-05	9.05e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.01e-05	8.02e-05	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—coronary artery disease	9.29e-06	7.4e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	8.08e-06	6.43e-05	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—coronary artery disease	6.6e-06	5.26e-05	CbGpPWpGaD
